CytRx Shareholders Get Del. Stock-Pump Suit Moving Again
By Jeff Montgomery ( September 2, 2016, 8:46 PM EDT) -- A Delaware class case accusing biopharmaceutical company CytRx Corp.'s board of sanctioning a brazen stock-pumping scheme came off the bench Friday when a vice chancellor lifted a stay imposed in May during battling over a similar case in California....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.